Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Apoptosis ; 20(4): 444-54, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25547913

ABSTRACT

Apoptotic cell death plays a pivotal role in the development and/or maintenance of several tissues including thymus. Deregulated thymic cell death is associated with autoimmune diseases including experimental autoimmune encephalomyelitis (EAE), a prototype murine model for analysis of human multiple sclerosis. Because Thy28 expression is modulated during thymocyte development, we tested whether Thy28 affects induction of EAE as effectively as antigen-induced thymocyte deletion using Thy28 transgenic (TG) mice. Thy28 TG mice showed partial resistance to anti-CD3 monoclonal antibody (mAb)-induced thymic cell death in vivo, as assessed by annexin V-expression and loss of mitochondrial membrane potential. The resistance to anti-CD3 mAb-induced cell death in Thy28 TG mice appeared to correlate with a decreased c-Jun N-terminal kinase phosphorylation and reduced down-regulation of Bcl-xL. Moreover, thymic hyperplasia was detected in Thy28 TG mice, although thymocyte development was unaltered. Development of peripheral lymphoid tissues including spleen and lymph nodes was also unaltered. Thy28 TG spleen T cells showed an increased production of IFN-γ, but not IL-17, in response to both anti-CD3 and anti-CD28 mAbs. Finally, Thy28 TG mice displayed accelerated induction of EAE as assessed by disease incidence, clinical score, and pathology following immunization with myelin oligodendrocyte glycoprotein compared with control WT mice. These findings suggest that modulation of Thy28 expression plays a crucial role in the determination of thymic cell fate, which may contribute to the development of EAE through proinflammatory cytokine production.


Subject(s)
Antibodies, Monoclonal/pharmacology , Apoptosis/drug effects , CD3 Complex/immunology , Multiple Sclerosis/metabolism , Nuclear Proteins/metabolism , Thymus Gland/cytology , Animals , Cell Death , Encephalomyelitis, Autoimmune, Experimental/genetics , Encephalomyelitis, Autoimmune, Experimental/metabolism , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Female , Humans , Male , Mice , Mice, Inbred C57BL , Multiple Sclerosis/genetics , Multiple Sclerosis/physiopathology , Nuclear Proteins/genetics , Thymocytes/cytology , Thymocytes/drug effects , Thymocytes/metabolism , Thymus Gland/metabolism
2.
Evol Comput ; 22(3): 361-403, 2014.
Article in English | MEDLINE | ID: mdl-24102647

ABSTRACT

Recent works raised the hypothesis that the assignment of a geometry to the decision variable space of a combinatorial problem could be useful both for providing meaningful descriptions of the fitness landscape and for supporting the systematic construction of evolutionary operators (the geometric operators) that make a consistent usage of the space geometric properties in the search for problem optima. This paper introduces some new geometric operators that constitute the realization of searches along the combinatorial space versions of the geometric entities descent directions and subspaces. The new geometric operators are stated in the specific context of the wireless sensor network dynamic coverage and connectivity problem (WSN-DCCP). A genetic algorithm (GA) is developed for the WSN-DCCP using the proposed operators, being compared with a formulation based on integer linear programming (ILP) which is solved with exact methods. That ILP formulation adopts a proxy objective function based on the minimization of energy consumption in the network, in order to approximate the objective of network lifetime maximization, and a greedy approach for dealing with the system's dynamics. To the authors' knowledge, the proposed GA is the first algorithm to outperform the lifetime of networks as synthesized by the ILP formulation, also running in much smaller computational times for large instances.


Subject(s)
Algorithms , Models, Theoretical , Signal Processing, Computer-Assisted , Wireless Technology
3.
Histol Histopathol ; 17(1): 239-46, 2002 01.
Article in English | MEDLINE | ID: mdl-11813874

ABSTRACT

Alzheimer's disease (AD) neuropathology is characterized by accumulation of "senile" plaques (SPs) and neurofibrillary tangles (NFTs) in vulnerable brain regions. SPs are principally composed of aggregates of up to 42/43 amino acid beta-amyloid (A beta) peptides. The discovery of familial AD (FAD) mutations in the genes for the amyloid precursor protein (APP) and presenilins (PSs), all of which increase A beta42 production, support the view that A beta is centrally involved in the pathogenesis of AD. A beta42 aggregates readily, and is thought to seed the formation of fibrils, which then act as templates for plaque formation. A beta is generated by the sequential intracellular cleavage of APP by beta-secretase to generate the N-terminal end of A beta, and intramembranous cleavage by gamma-secretase to generate the C-terminal end. Cell biological studies have demonstrated that A beta is generated in the ER, Golgi, and endosomal/lysosomal system. A central question involving the role of A beta in AD concerns how A beta causes disease and whether it is extracellular A beta deposition and/or intracellular A beta accumulation that initiates the disease process. The most prevalent view is that SPs are composed of extracellular deposits of secreted A beta and that A beta causes toxicity to surrounding neurons as extracellular SP. The recent emphasis on the intracellular biology of APP and A beta has led some investigators to consider the possibility that intraneuronal A beta may directly cause toxicity. In this review we will outline current knowledge of the localization of both intracellular and extracellular A beta.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/toxicity , Amyloid beta-Protein Precursor/metabolism , Humans , Plaque, Amyloid/pathology
4.
Int J Neural Syst ; 11(3): 265-70, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11574964

ABSTRACT

This paper presents a new scheme for training MLPs which employs a relaxation method for multi-objective optimization. The algorithm works by obtaining a reduced set of solutions, from which the one with the best generalization is selected. This approach allows balancing between the training error and norm of network weight vectors, which are the two objective functions of the multi-objective optimization problem. The method is applied to classification and regression problems and compared with Weight Decay (WD), Support Vector Machines (SVMs) and standard Backpropagation (BP). It is shown that the systematic procedure for training proposed results on good generalization neural models, and outperforms traditional methods.


Subject(s)
Algorithms , Neural Networks, Computer
5.
Hybridoma ; 19(4): 331-4, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11001406

ABSTRACT

Human immunodeficiency virus type 1 (HIV-1) virion is known to carry a number of cellular components including cellular topoisomerase I. Previously, we have demonstrated that topoisomerase I enhances HIV-1 cDNA synthesis in reverse transcription (RT) assays in vitro. In the present study, we have produced six monoclonal antibodies (MAbs) against human topoisomerase I. The MAbs suppressed nicking/closing of supercoiled DNA and cDNA synthesis in an endogenous reverse transcription (ERT) assay using a detergent-disrupted HIV-1 virion. Thus, the results suggest that topoisomerase I plays an important role in RNA-directed DNA polymerization.


Subject(s)
Antibodies, Monoclonal/pharmacology , DNA Replication/drug effects , DNA Topoisomerases, Type I/immunology , DNA, Complementary/biosynthesis , DNA, Viral/drug effects , HIV-1/drug effects , Animals , Antibody Specificity/immunology , Blotting, Southern , Cell Line , DNA Topoisomerases, Type I/isolation & purification , Enzyme-Linked Immunosorbent Assay , Female , HIV-1/genetics , HeLa Cells , Humans , Mice , Mice, Inbred BALB C , RNA, Viral/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Transfection , Virus Replication
6.
Clin Diagn Lab Immunol ; 6(6): 983-5, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10548598

ABSTRACT

We established four hybridoma cell lines producing monoclonal antibodies (MAbs) against 14-3-3 proteins. Immunoblot analysis revealed that epsilon and gamma isoforms were specifically increased in premortem cerebrospinal fluid samples from patients with sporadic Creutzfeldt-Jakob disease. Furthermore, dot immunoblot analysis showed that MAbs were more specific for native antigen than polyclonal antibodies were.


Subject(s)
Creutzfeldt-Jakob Syndrome/cerebrospinal fluid , Creutzfeldt-Jakob Syndrome/diagnosis , Proteins , Tyrosine 3-Monooxygenase , 14-3-3 Proteins , Antibodies, Monoclonal , Antibody Specificity , Humans , Hybridomas , Immunoblotting , Isomerism , Proteins/chemistry , Proteins/immunology , Proteins/metabolism
7.
J Neurovirol ; 5(3): 300-7, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10414520

ABSTRACT

To analyze the antigenicity of peptides derived from bovine prion protein (PrP) cDNA, we immunized rabbits with four synthetic peptides and compared the immunoreactivity of antibodies to PrPs from various species by immunoblotting and immunohistochemistry. Two of the antibodies reacted strongly with all PrPs. The other antibodies, raised against overlapping peptides close to two glycosylation sites, did not recognize PrPSc-mouse but did recognize PrPSc-sheep which contains two sugar residues and PrPCJD with or without a sugar residue. Our results suggest that these antibodies may have species-specificity for both glycosylation status and amino acid sequences of the protein. In conclusion, we identified two regions in bovine-PrP which appear suitable for raising antibodies that detect various kinds of PrPs, and one region (Ab103-121) which appears suitable for raising antibodies that detect several species of PrPs. These antibodies may be useful for diagnosing prion diseases and for researching their pathogenesis.


Subject(s)
Peptides/immunology , Prions/immunology , Amino Acid Sequence , Animals , Antibody Specificity , Blotting, Western , Brain/metabolism , Cattle , Cerebellum/metabolism , Creutzfeldt-Jakob Syndrome/metabolism , Encephalopathy, Bovine Spongiform/metabolism , Epitopes/metabolism , Humans , Immunohistochemistry , Mice , Molecular Sequence Data , Peptides/genetics , Prions/genetics , Rabbits , Sequence Alignment , Sheep , Species Specificity
8.
Virology ; 256(2): 371-80, 1999 Apr 10.
Article in English | MEDLINE | ID: mdl-10191202

ABSTRACT

The molecular processes involved in retrovirus assembly and budding formation remain poorly understood. The gag-pro-pol genes of human lymphotropic T-cell virus type II (HTLV-II) are translated into Gag, Gag-Pro, or Gag-Pro-Pol by frameshift events. In the present study, we investigated the roles of the gag, pro, and pol regions of HTLV-II in viral particle formation using recombinant baculoviruses. In this study we could successfully produce mature HTLV-II viral particles containing core structures using a construct expressing the entire gag-pro-pol region. We also investigated the role of the pol region in particle formation. Deletion of the pol region affects viral particle assembly or release very little, indicating that the gag-pro region is sufficient for viral particle formation and maturation. Expression of the Gag proteins alone or Gag proteins with inactivated viral proteases (Pro) resulted in the formation of viral particles; however, these particles did not contain core structures. These results suggest the intracellular expression of Gag with Pro of HTLV-II is essential for the production of mature virus particles, whereas that of Pol is not.


Subject(s)
Genetic Vectors , Human T-lymphotropic virus 2/physiology , Nucleopolyhedroviruses , Virus Assembly , Animals , Cell Line , Genes, gag , Genes, pol , Humans , Moths , Mutagenesis , Recombination, Genetic , Retroviridae Proteins, Oncogenic/biosynthesis , Virion
SELECTION OF CITATIONS
SEARCH DETAIL
...